Concepedia

Alex Hoyle

AH

Statistics

Publications

15

Citations

2.4K

H-Index

13

Active since

2018

Affiliations

University College London(Current)

MRC Clinical Trials Unit at UCL

Institute of Cancer Research

University of Manchester

Cancer Research UK Manchester Institute

Alex Hoyle is an author at University College London specializing in medicine, oncology, and urology.

Top concepts

Publications per year

2018–2023

15

Publications

15

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Christopher Parker, Nicholas D. James, Chris Brawley et al. · The Lancet · 2018 · 1.2K citations · Full text

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

N.W. Clarke, Amin Ali, Fiona C. Ingleby et al. · Annals of Oncology · 2019 · 389 citations · Full text

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

Alex Hoyle, Adnan Ali, Nicholas D. James et al. · European Urology · 2019 · 199 citations · Full text

, , +4

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer

Adnan Ali, Alex Hoyle, Áine Haran et al. · JAMA Oncology · 2021 · 129 citations · Full text

Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial

Chris Parker, Nicholas D. James, Chris Brawley et al. · PLoS Medicine · 2022 · 112 citations · Full text

1–5 of 15